Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease

被引：0
|
作者：
Elżbieta Kimak
Bartosz Zięba
Dariusz Duma
Janusz Solski
机构：
[1] Medical University,Department of Laboratory Diagnostics
[2] Department of Cardiology of the Provincial Specialistics Cardinal Stefan Wyszynski Hospital,undefined
来源：
Lipids in Health and Disease | / 17卷
关键词：
Myeloperoxidase; Inflammatory markers; Lipids; Lipoproteins; Stable coronary;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Inflammatory Markers and Their Role in Assessing Prognosis of Patients With Stable Coronary Artery Disease After Coronary Stenting
    Tomilova, D. I.
    Byazrova, F. F.
    Lopukhova, V. V.
    Buza, V. V.
    Karpov, Yu. A.
    KARDIOLOGIYA, 2015, 55 (11) : 88 - 93
  • [22] Serum levels of ceruloplasmin and myeloperoxidase in patients with stable coronary artery disease
    Monica Yapura, Viviana
    Fernanda Bustos, Maria
    Beatriz Di Carlo, Maria
    Lopez Mingorance, Fabiana Norma
    Vazquez Blanco, Manuel
    Alberto Negri, Gustavo
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2013, 47 (01): : 53 - 59
  • [23] Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease
    Kubala, Lukas
    Lu, Guijing
    Baldus, Stephan
    Berglund, Lars
    Eiserich, Jason P.
    CLINICA CHIMICA ACTA, 2008, 394 (1-2) : 59 - 62
  • [24] Coronary ostial assessment of myeloperoxidase level correlated to severity of coronary artery disease
    Hanboly, Noha Hassanin
    Baghdady, Yasser Kamel Gaber
    Ahmed, Mohammed Helmy Aly
    Hashad, Assem Abdelaziz
    COR ET VASA, 2021, 63 (06) : 646 - 650
  • [25] Coronary scoring and inflammatory markers in coronary artery disease patients
    Chevtchenko, AO
    Tchervjakova, NV
    Kochetova, EV
    Shevchenko, OP
    CLINICA CHIMICA ACTA, 2005, 355 : S85 - S85
  • [26] Serum lipoprotein (a) level and severity of coronary artery disease
    Batalla, A
    Braga, S
    Reguero, JR
    Cubero, GI
    HEART AND VESSELS, 2002, 16 (05) : 214 - 214
  • [27] Serum lipoprotein (a) level and severity of coronary artery disease
    A. Batalla
    Socorro Braga
    Julián R. Reguero
    Gustavo I. Cubero
    Heart and Vessels, 2002, 16 : 214 - 214
  • [28] Lipid parameters in acute coronary syndromes versus stable coronary artery disease with respect to metabolic syndrome
    Vonbank, Alexander
    Saely, Christoph H.
    Rein, Philipp
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 : 7 - 8
  • [29] Increased myeloperoxidase level in coronary artery disease and its relationship with severity of the disease
    Yavuz, B.
    Deniz, A.
    Tokgozoglu, L.
    Duzguncinar, O.
    Demirpence, E.
    Bayrak, T.
    Bayrak, A.
    Aytemir, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 524 - 524
  • [30] Prognostic value of simultaneous assessment of lipid and inflammatory markers in patients with stable coronary heart disease
    Hoffmeister, A
    Rothenbacher, D
    Kunze, M
    Brenner, H
    Koenig, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 238A - 238A
12345